Company Encyclopedia
View More
name
YSB
09885.HK
YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that include Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations.
180.82 B
09885.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
Health Care DistributorsIndustry
Industry Ranking1/21
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE3.97%C
    • Profit Margin0.46%C
    • Gross Margin11.22%E
  • Growth ScoreB
    • Revenue YoY6.42%C
    • Net Profit YoY7085.42%A
    • Total Assets YoY29.98%A
    • Net Assets YoY17.23%A
  • Cash ScoreB
    • Cash Flow Margin21935.20%A
    • OCF YoY6.42%C
  • Operating ScoreA
    • Turnover3.13A
  • Debt ScoreD
    • Gearing Ratio66.45%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    YSB confirms that business operations are normal, and executive directors increase their shareholding

    YSB announced that on November 6, it repurchased 400,000 shares at an average price of 8.0883 yuan per share, with a total repurchase amount of approximately 3.24 million yuan. On the same day, Executive Director Mr. Chen Fei purchased a total of 200,000 shares in the open market. The company stated that, after reasonable inquiries, the board confirmed that it is not aware of any reasons that could lead to abnormal fluctuations in the stock price and trading volume. It also confirmed that business operations remain normal, and there have been no significant changes in business operations and financial conditions to date

    AASTOCKS·
    HK
    09885
    -2.41%
    AASTOCKS·
    HK
    09885
    -2.41%

    The flu season is approaching, YSB's "Supply Protection" drives sales growth

    YSB ensured drug supply through a digital supply chain system during the peak flu season, with sales increasing by 36% year-on-year. Among them, the demand for Oseltamivir phosphate granules and capsules surged by 120%. The platform collaborated with multiple pharmaceutical companies to ensure stable supply of core drugs and optimized inventory management through a smart supply chain system. The self-owned brand "Le Yao Shi" saw a sales increase of over 135% for cold medications. In addition, YSB's immune small box supports rapid testing, enhancing the capacity of grassroots medical services

    Zhitong·
    HK
    09885
    -2.41%
    Zhitong·
    HK
    09885
    -2.41%

    Hong Kong Stock Movement: IVD MEDICAL fell 12.86%, with no news support, the sector's volatility has attracted market attention

    IVD MEDICAL fell 12.86%; BAIYUNSHAN PH rose 3.05%, with a trading volume of HKD 87.8 million; YSB fell 2.27%, with a trading volume of HKD 46.35 million; SINOPHARM rose 0.67%, with a trading volume of HKD 46.33 million; SH PHARMA rose 0.24%, with a market value of HKD 45.5 billion

    HK Stock Movers Tracker·
    HK
    01931
    -0.88%
    HK
    00874
    +0.37%
    HK
    09885
    -2.41%
    HK Stock Movers Tracker·
    HK
    01931
    -0.88%
    HK
    00874
    +0.37%
    HK
    09885
    -2.41%

    On October 27th, YSB spent HKD 977,100 to repurchase 100,000 shares

    According to the Zhitong Finance APP, YSB announced that on October 27, 2025, the company spent HKD 977,100 to repurchase 100,000 shares

    Zhitong·
    HK
    09885
    -2.41%
    Zhitong·
    HK
    09885
    -2.41%

    On October 21st, YSB spent HKD 1.0901 million to repurchase 100,000 shares

    According to the announcement from YSB, on October 21, 2025, the company repurchased shares based on the 2025 share repurchase authorization. A total of 100,000 shares were repurchased in the market, with a total repurchase amount of approximately HKD 1.0901 million (excluding commissions and other expenses), and the average repurchase price was HKD 10.9013 per share

    Zhitong·
    HK
    09885
    -2.41%
    Zhitong·
    HK
    09885
    -2.41%
    © 2025 Longbridge｜Disclaimer